NYSE:MCKHealthcare
McKesson’s Strong Quarter Highlights Shift Toward Post Separation Focus
McKesson (NYSE:MCK) reported strong fiscal third quarter results, highlighting continued momentum across key segments including oncology, biopharma services, and pharmaceutical distribution.
The company outlined substantial progress toward separating its medical surgical business, with a planned IPO targeted by the second half of 2027.
Recent acquisitions and technology investments were cited as important contributors to the period's performance and ongoing business evolution.
The planned...